Ted Karkus serves as the CEO and Chairman of ProPhase Labs, where he leads the company's diverse businesses. ProPhase Labs operates as a biotech, genomics, and diagnostics company, focusing on high growth, innovation, and execution excellence.

Under his leadership, ProPhase Labs has expanded into industry-leading CLIA labs and diversified through the acquisition of genomics leader Nebula Genomics, which provides whole genome sequencing to consumers, researchers, and pharmaceutical companies.